Position in YARW
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16
+$2 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 44 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in YARW Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $2,305,139 across 79 Biotechnology names. YARW ranks #74 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
7,833 | $426,193 | |
| 2 | TWST |
Twist Bioscience Corp
|
1,773 | $182,406 | |
| 3 | CRVS |
Corvus Pharmaceuticals, Inc.
|
10,195 | $152,313 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
1,156 | $141,702 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
3,788 | $134,057 | |
| 6 | CTMX |
CytomX Therapeutics, Inc.
|
27,988 | $104,955 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
1,764 | $96,914 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
2,387 | $93,379 |
All Filings in YARW
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16 | 25 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $14 | 25 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14 | 25 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8 | 25 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41 | 25 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $39 | 25 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||